Your session is about to expire
← Back to Search
PSMA PET/CT for Cancer
Study Summary
This trial is testing if two different types of PET scans can be used to detect and stage a type of cancer that expresses a certain protein.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What potential risks may arise from PSMA PET/CT procedures?
"The safety of PSMA PET/CT was assigned a score of 2, as this is currently in its Phase 2 trial period. As such there is some data verifying the medication's security but no evidence yet to verify efficacy."
Who qualifies to partake in this research initiative?
"A total of 150 individuals between the ages of 18 to 120 who are currently struggling with malignancies will be admitted into this clinical trial. To participate, they must have an ECOG performance status rating from 0-3 and remain under a referring physician's care. Furthermore, it is required that participants can comfortably tolerate physical/logistical requirements such as 40 minutes spent laying supine with arms above their head and intravenous cannulation."
Is there an age limit on the enrollment of participants in this research endeavor?
"The prerequisites for participation in this research study specify that volunteers must be between 18 to 120 years old. Additionally, there exist 60 trials exclusively for minors and 429 studies focusing on seniors."
Is enrollment for this clinical investigation open at the moment?
"As per clinicaltrials.gov, this medical trial is not presently looking for individuals to join. The first posting was on July 25th 2019 and the latest update arrived in December 2021. While this study is inactive at present, 482 other studies are recruiting patients currently."
Share this study with friends
Copy Link
Messenger